identification platelet adp receptor targeted antithrombotic drugs
platelets crucial role maintenance normal haemostasis perturbations system can lead pathological thrombus formation vascular occlusion resulting stroke myocardial infarction unstable angina adp released damaged vessels red blood cells induces platelet aggregation activation integrin gpiib-iiia subsequent binding fibrinogen adp also secreted platelets activation providing positive feedback potentiates actions many platelet activators adp mediates platelet aggregation action two g-protein-coupled receptor subtypes p2y receptor couples gq mobilizes intracellular calcium ions mediate platelet shape change aggregation second adp receptor required aggregation variously called p2yadp p2yac p2ycyc p2tac coupled inhibition adenylyl cyclase gi molecular identity gi-linked receptor still elusive even though target efrcacious antithrombotic agents ticlopidine clopidogrel- ar-c66096 ref describe cloning receptor designated p2y provide evidence patient bleeding disorder defect gene cloning p2y12 receptor facilitate development better antiplatelet agents treat cardiovascular diseases
